A 71-year-old male was referred to the Ophthalmology Department with a choroidal metastasis
shown in wide-field colour and optical coherence tomography images (A). He was found to have a primary lung adenocarcinoma, and bronchoscopic biopsies
revealed tumour expression of programmed death-ligand 1. Subsequently, the immunotherapeutic
agent pembrolizumab was started.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of OphthalmologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: January 24, 2023
Accepted:
January 6,
2023
Received in revised form:
December 19,
2022
Received:
November 17,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
© 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.
